The exosome diagnostics and therapeutics market was estimated to be US$ 76.03 Mn in 2021 and US$ xx Bn in 2023. It is expected to reach US$ 1542.45 Mn by 2031 and record a CAGR of 35.1% until 2031. Continued advancements in exosome research and technology, improved isolation techniques, and exosome engineering to enhance therapeutic applications will likely remain key exosome diagnostics and therapeutic market trends.
Exosome Diagnostics and Therapeutics Market Analysis
The increasing prevalence of chronic diseases is expected to grow the exosome diagnostics and therapeutics market. Exosomes are involved in the pathogenesis of diseases, such as cancer, pregnancy disorders, neurodegenerative diseases, and cardiovascular diseases, and are potential non-invasive biomarkers for the diagnosis, prognosis, and therapeutics of a myriad of diseases. As per the European Commission, there were 2.74 million new cancer cases in the EU Member States.
Exosome Diagnostics and Therapeutics Market Overview
The global exosome diagnostics and therapeutics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The market growth in this region is expected due to factors such as increasing demand for novel diagnostic therapeutics, developing overall healthcare infrastructure, and increasing awareness regarding benefits offered by exosome-based diagnostics. However, lack of expertise is likely to restrain the market growth to a certain extent.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Exosome Diagnostics and Therapeutics Market: Strategic Insights
Market Size Value in US$ 41.6.33 Million in 2019 Market Size Value by US$ 358.91 Million by 2027 Growth rate CAGR of 32.2% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Exosome Diagnostics and Therapeutics Market: Strategic Insights
| Market Size Value in | US$ 41.6.33 Million in 2019 |
| Market Size Value by | US$ 358.91 Million by 2027 |
| Growth rate | CAGR of 32.2% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Exosome Diagnostics and Therapeutics Market Drivers and Opportunities
Rise in Research and Development Activities is Likely to Favor The Market.
Several market players and healthcare organizations are implementing strategies to boost research and development activities on exosome applications. For instance, a research study on ‘Exosomes: Potential Disease Biomarkers and New Therapeutic Targets’ was conducted in the Department of Medicine, Universidad del Norte, Barranquilla, Colombia. The study presented perspectives on the use of exosomes in future clinical practice.
Owing to these factors, exosome diagnostics and therapeutic is gaining importance.
Growing Preference for Non-invasive and Novel Diagnostic Procedure– An Opportunity in Exosome Diagnostics and Therapeutics Market
Exosomes facilitate intercellular communications through the exchange of lipids and proteins between the exosome-producing cells and target cells. Moreover, they enable intracellular communication through the horizontal transfer of biomolecules between cells and their microenvironment. Ongoing research studies have demonstrated the imperative physiological roles of exosomes in the diagnosis of cardiovascular, immune, and neural diseases, as well as in the pathogenesis of chronic conditions such as cancer. A significant number of startups are coming into the market with an aim to fulfill the need of novel invasive diagnostic procedures. For instance, in 2015, a group of researchers launched a new company, Exocan, with the major aim of engaging in the development of an exosomes-based diagnostic platform for accurate and noninvasive diagnosis of cancer with the help of urine and saliva.
Exosome Diagnostics and Therapeutics Market Report Segmentation Analysis
Key segments that contributed to the exosome diagnostics and therapeutics market analysis derivation are services and applications.
- Based on application, the exosome diagnostics and therapeutics market is segmented into diagnostic and therapeutic applications. In 2023, the diagnostic applications segment held the largest share of the market. Moreover, the therapeutic application segment is expected to grow at the fastest rate during the forecast period.
- By product, the exosome diagnostics and therapeutics market is segmented into instruments, reagents, and software. The instrument segment held the largest share of the market in 2019, and the software segment is estimated to register the highest CAGR in the market during the forecast period.
- The exosome diagnostics and therapeutics market has been segmented by end-user into cancer institutes, hospitals, diagnostic centers, and others. In 2023, the cancer institute segment held the largest share of the market by end user. Moreover, the same segment is expected to grow fastest during the forecast period.
Exosome Diagnostics and Therapeutics Market Share Analysis by Geography
The geographic scope of the exosome diagnostics and therapeutics market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.
North America includes the US, Canada, and Mexico. North America holds the most significant share in the exosome diagnostics and therapeutic market, with the US holding the largest market share, followed by Canada. The US holds the largest share of the exosome diagnostics and therapeutics market, which is attributed to increased demand for the use of exosomes as biomarkers in the diagnosis of cancer, along with the increasing prevalence of cancer, the aging population, and lifestyle changes. Additionally, a robust product pipeline, the presence of major players, and well-developed regulatory policies are projected to drive the North American exosome diagnostic and therapeutic market during the forecast period.
Asia Pacific region is expected to be the fastest-growing region among all other regions. The growth of the market in the Asia Pacific region is expected to grow at a faster pace owing to factors such as favorable regulatory scenarios, increasing need for superior treatment solutions, and increasing focus on exosome research and development activities. Additionally, expanding healthcare infrastructure and increasing investments in order to boost research activities are projected to drive the Asia Pacific exosome diagnostic and therapeutic market during the forecast period.
Exosome Diagnostics and Therapeutics Market Report Scope
Exosome Diagnostics and Therapeutic Market News and Recent Developments
The exosome diagnostics and therapeutics market is evaluated by gathering qualitative and quantitative data post post-primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for exosome diagnostics and therapeutic strategies:
- In July 2023, Texas–based Direct Biologics announced promising results from a Phase II trial showing that its exosome, ExoFlo, reduced mortality in long COVID patients with acute respiratory distress syndrome. (Source: Company Press Release)
- In January 2024, EXO Biologics SA, a Belgian biotech company that develops biopharmaceuticals using exosomes to treat rare diseases, launched ExoXpert, a contract development and manufacturing organization (CDMO) specializing in exosomes. (Source: Company Press Release)
Exosome Diagnostics and Therapeutic Market Report Coverage and Deliverables
The “Exosome Diagnostics and Therapeutic Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product ; Service ; Application ; & End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Exosome Diagnostics and Therapeutics Market
May 2024
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
May 2024
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
May 2024
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
May 2024
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
May 2024
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
May 2024
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2024
Fall Management Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensor Pads, Floor Mat, Hip Protectors, Alert Systems, Communication Devices, and Other Products), Application (Fall Detection Systems, Fall Prevention Equipment, and Post-Fall Monitoring and Response Systems), Age Group [Elderly Population (65 and Above) and Adults (18–64 years)], End User (Hospitals and Clinics, Nursing Homes, Home Care Settings, and Other End Users), and Geography
May 2024
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For